Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 7/2015

Open Access 01-07-2015 | Original Contributions

Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT)

Authors: Alper Celik, Surendra Ugale, Hasan Ofluoglu, Muharrem Asci, Bahri Onur Celik, Erol Vural, Mustafa Aydin

Published in: Obesity Surgery | Issue 7/2015

Login to get access

Abstract

Background

In this study, we specifically aimed to analyze the technical and safety aspects of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) in patients with type 2 diabetes (T2DM).

Methods

A total of 360 patients with type 2 diabetes who underwent a DSIT procedure within the past 2-year period (2011–2013) were analyzed. Operation time, length of hospital stay, perioperative and postoperative complications, and mortality were recorded and analyzed.

Results

The participants consisted of 229 males (63.6 %) and 131 females (36.4 %). Mean duration of follow-up was 12.4 months (range, 6–31). One early and two late mortalities occurred. Early mortality was due to an anastomotic leak, and late mortalities were related to myocardial infarction and a traffic accident. Leakage and bleeding were the most common surgical complications. The total number of surgical complications was 22 (6.1 %). Of those, 19 occurred within the first month (early) and 3 occurred after the first month (late). Among early complications, seven (1.94 %) required re-operation, two patients (0.55 %) required endoscopic treatment, and the remaining ten were managed conservatively. Late surgical complications (sleeve angulation) were noted in three patients (0.83) and were treated by endoscopic stents. Surgery-related non-surgical complications occurred in 19 cases (5.2 %), and neurological complications were noted in 11 patients (3.05 %). Additional surgical intervention was required in 26 patients (7.22 %). Of those, 15 (4.16 %) required cholecystectomy.

Conclusions

Our data demonstrate that DSIT is a technically feasible operation and can be safely performed in type 2 diabetic patients with acceptable complication and mortality rates.
Literature
1.
2.
Bermudez DM, Pories WJ. New technologies for treating obesity. Minerva Endocrinol. 2013;38:165–72.PubMed
3.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Eng J Med. 2012;366:1567–85.CrossRef
4.
Dejardin DC, Sabench F, Hernandez GMA, et al. Effectiveness of sleeve gastrectomy as type 2 diabetes treatment: relationship with the technique and complications. In Diabetes Surgery Eds: Garciacaballero M, Tinahones FJ, Cohen RV. McGraw Hill publication. 2010, 195–206.
5.
DePaula AL, Macedo ALV, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.PubMedCrossRef
6.
Vencio S, Stival A, Halpern A, et al. Early mechanisms of glucose improvement following laparoscopic ileal interposition associated with a sleeve gastrectomy evaluated by the euglycemic hyperinsulinemic clamp in type 2 diabetic patients with BMI below 35. Dig Surg. 2011;28(4):293–8.PubMedCrossRef
7.
DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc. 2008;22:2670–8.PubMedCrossRef
8.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
9.
Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:S290–6.PubMedCrossRef
10.
Shea JA, Healey MJ, Berlin JA, et al. Mortality and complications associated with laparoscopic cholecystectomy. A meta-analysis Ann Surg. 1996;224:609–20.
11.
Gonzalez R, Sarr MG, Smith CD, et al. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for morbid obesity. J Am Coll Surg. 2007;204(1):47–55.PubMedCrossRef
12.
Wittgrove AC, Clarke GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 months follow up. Obes Surg. 2000;10(3):233–9.PubMedCrossRef
13.
Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil. 2014;26(5):611–24.PubMedCentralPubMedCrossRef
14.
Dorfman D, George MC, Tamler R, et al. Pruritus induced self injury behavior: an overlooked risk factor for amputation in diabetic neuropathy? Diabetes Res Clin Pract. 2014;103(3):47–8.CrossRef
15.
Berger TG, Shive M, Harper GM. Pruritus in the older patient: a clinical review. JAMA. 2013;310(22):2443–50.PubMedCrossRef
16.
Kirchhoff BA, Lugar HM, Smith SE, et al. Hypoglycaemia-induced changes in regional brain volume and memory function. Diabet Med. 2013;30(4):151–6.CrossRef
17.
Chalmers J, Risk MT, Kean DM, et al. Severe amnesia after hypoglycemia. Clinical, psychometric, and magnetic resonance imaging correlations. Diabetes Care. 1991;14(10):922–5.PubMedCrossRef
18.
Müller-Stich BP, Fischer L, Kenngott HG, et al. Gastric bypass leads to improvement of diabetic neuropathy independent of glucose normalization—results of a prospective cohort study (DiaSurg 1 study). Ann Surg. 2013;258(5):760–6.PubMedCrossRef
19.
Chang CG, Adams-Huet B, Provost DA. Acute post gastric reduction surgery neuropathy. Obes Surg. 2004;14:182–9.PubMedCrossRef
20.
Aluka KJ, Turner PL, Fullum TM. Guillain-Barré syndrome and postbariatric surgery polyneuropathies. JSLS. 2009;13(2):250–3.PubMedCentralPubMed
21.
22.
Thaisetthawatkul P, Collazo-Clavell ML, Sarr MG, et al. Good nutritional control may prevent polyneuropathy after bariatric surgery. Muscle Nerve. 2010;42(5):709–14.PubMedCentralPubMedCrossRef
23.
Rudnicki SA. Prevention and treatment of peripheral neuropathy after bariatric surgery. Curr Treat Options Neurol. 2010;12(1):29–36.PubMedCrossRef
24.
Milants C, Lempereur S, Dubuisson A. Bilateral peroneal neuropathy following bariatric surgery. Neurochirurgie. 2013;59(1):50–2.PubMedCrossRef
25.
Philippi N, Vinzio S, Collongues N, et al. Peripheral neuropathies after bariatric surgery. Rev Neurol (Paris). 2011;167(8–9):607–14.CrossRef
26.
DePaula AL, Stival A, Halpern A, et al. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg. 2011;35(1):102–8.PubMedCrossRef
27.
Moon RC, Teixeira AF, DuCoin C, et al. Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis. 2014;10(1):64–8.PubMedCrossRef
28.
Nagem RG, Lázaro SA, Oliveira RM, et al. Gallstone-related complications after Roux-en-Y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.PubMedCrossRef
29.
Nagem R, Lázaro-da-Silva A. Cholecystolithiasis after gastric bypass: a clinical, biochemical, and ultrasonographic 3-year follow-up study. Obes Surg. 2012;22(10):1594–9.PubMedCrossRef
30.
Raziel A, Sakran N, Szold A, et al. Concomitant bariatric and ventral/incisional hernia surgery in morbidly obese patients. Surg Endosc. 2014;28(4):1209–12.PubMedCrossRef
31.
Scozzari G, Zanini M, Cravero F, et al. High incidence of trocar site hernia after laparoscopic or robotic Roux-en-Y gastric bypass. Surg Endosc. 2014. PubMed PMID: 24789133.
32.
Elms L, Moon RC, Varnadore S, et al. Causes of small bowel obstruction after Roux-en-Y gastric bypass: a review of 2,395 cases at a single institution. Surg Endosc. 2014;28:1624–8.PubMedCrossRef
33.
Matarasso A, Schneider LF, Barr J. The incidence and management of secondary abdominoplasty and secondary abdominal contour surgery. Plast Reconstr Surg. 2014;133(1):40–50.PubMedCrossRef
Metadata
Title
Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT)
Authors
Alper Celik
Surendra Ugale
Hasan Ofluoglu
Muharrem Asci
Bahri Onur Celik
Erol Vural
Mustafa Aydin
Publication date
01-07-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 7/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1518-1

Other articles of this Issue 7/2015

Obesity Surgery 7/2015 Go to the issue

Letter to Editor/LED Reply

Response to the Comment on “Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model”

Original Contributions

Type 2 Diabetes Remission After Gastric Bypass: What Is the Best Prediction Tool for Clinicians?

Original Contributions

Laparoscopic Sleeve-Collis-Nissen Gastroplasty: a Safe Alternative for Morbidly Obese Patients with Gastroesophageal Reflux Disease

Original Contributions

Road Running After Gastric Bypass for Morbid Obesity: Rationale and Results of a New Protocol

Original Contributions

Revisional Laparoscopic Gastric Pouch Resizing for Inadequate Weight Loss After Roux-en-Y Gastric Bypass

New Concept

Treatment of Leaks Following Sleeve Gastrectomy by Endoscopic Internal Drainage (EID)